Literature DB >> 26445333

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [(99m)Tc(MIBI)₆].

D P Faria1, C A Buchpiguel2, F L N Marques2.   

Abstract

Knowledge of the radiochemical purity of radiopharmaceuticals is mandatory and can be evaluated by several methods and techniques. Planar chromatography is the technique normally employed in nuclear medicine since it is simple, rapid and usually of low cost. There is no standard system for the chromatographic technique, but price, separation efficiency and short time for execution must be considered. We have studied an alternative system using common chromatographic stationary phase and alcohol or alcohol:chloroform mixtures as the mobile phase, using the lipophilic radiopharmaceutical [(99m)Tc(MIBI)₆]⁺ as a model. Whatman 1 modified phase paper and absolute ethanol, Whatman 1 paper and methanol:chloroform (25:75), Whatman 3MM paper and ethanol:chloroform (25:75), and the more expensive ITLC-SG and 1-propanol:chloroform (10:90) were suitable systems for the direct determination of radiochemical purity of [(99m)Tc(MIBI)₆]⁺ since impurities such as (99m)Tc-reduced-hydrolyzed (RH), (99m)TcO(4)(-) and [(99m)Tc(cysteine)₂]⁻ complex were completely separated from the radiopharmaceutical, which moved toward the front of chromatographic systems while impurities were retained at the origin. The time required for analysis was 4 to 15 min, which is appropriate for nuclear medicine routines.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26445333      PMCID: PMC4617116          DOI: 10.1590/1414-431X20144489

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  Evaluation of an alternative radiochemical purity testing method for technetium-99m sestamibi.

Authors:  A L Luebke; D M Wilary; D W Mahoney; J C Hung
Journal:  J Nucl Med Technol       Date:  2000-12

2.  Optimal conditions of 99mTc eluate for the radiolabeling of 99mTc-sestamibi.

Authors:  J C Hung; T J Herold; R J Gibbons
Journal:  Nucl Med Biol       Date:  1996-07       Impact factor: 2.408

3.  Routine determination of radiochemical purity of 99mTc-MIBI.

Authors:  A Proulx; J R Ballinger; K Y Gulenchyn
Journal:  Int J Rad Appl Instrum A       Date:  1989

Review 4.  64Cu-labeled phosphonium cations as PET radiotracers for tumor imaging.

Authors:  Yang Zhou; Shuang Liu
Journal:  Bioconjug Chem       Date:  2011-07-01       Impact factor: 4.774

5.  The influence of generator eluate on the radiochemical purity of 99Tcm-sestamibi prepared using fractionated Cardiolite kits.

Authors:  P Varelis; S L Parkes; M T Poot
Journal:  Nucl Med Commun       Date:  1998-07       Impact factor: 1.690

Review 6.  Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis.

Authors:  Hosahalli K Mohan; Kenneth A Miles
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

7.  Impact of myocardial salvage assessed by (99m)Tc-sestamibi scintigraphy on cardiac autonomic function in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.

Authors:  Axel Bauer; Julinda Mehilli; Petra Barthel; Alexander Müller; Adnan Kastrati; Kurt Ulm; Albert Schömig; Marek Malik; Georg Schmidt
Journal:  JACC Cardiovasc Imaging       Date:  2009-04

8.  Rapid quality control of 99Tcm-sestamibi.

Authors:  R M Reilly; M So; J Polihronis; S Houle
Journal:  Nucl Med Commun       Date:  1992-09       Impact factor: 1.690

9.  Rapid preparation and quality control method for technetium-99m-2-methoxy isobutyl isonitrile (technetium-99m-sestamibi).

Authors:  J C Hung; M E Wilson; M L Brown; R J Gibbons
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.